Flesh-eating Streptococcus pyogenes triggers the expression of receptor activator of nuclear factor-κB ligand
Hidenori Matsui1, Yuriko Nakatani2,3, Haruno Yoshida2
1Department of Infection Control and Immunology, Kitasato Institute for Life Sciences, Kitasato University, Minato-ku, Tokyo, 108-8641, Japan. hmastui@lisci.kitasato-u.ac.jp.
Abstract:
Human CD46 is a receptor for the M protein of group A streptococcus (GAS). The emm1 GAS strain GAS472 was isolated from a patient suffering from streptococcal toxic shock-like syndrome. Human CD46-expressing transgenic (Tg) mice developed necrotizing fasciitis associated with osteoclast-mediated progressive and severe bone destruction in the hind paws 3 days after subcutaneous infection with 5 × 10(5) colony-forming units of GAS472. GAS472 infection induced expression of the receptor activator of nuclear factor-κB ligand (RANKL) while concomitantly reducing osteoprotegerin expression in the hind limb bones of CD46 Tg mice. Micro-computed tomography analysis of the bones suggested that GAS472 infection induced local bone erosion and systemic bone loss in CD46 Tg mice. Because treatment with monoclonal antibodies (mAbs) against mouse CD4(+) and CD8(+) T lymphocytes did not inhibit osteoclastogenesis, T lymphocyte-derived RANKL was not considered a major contributor to massive bone loss during GAS472 infection. However, immunohistochemical analysis of the hind limb bones showed that GAS472 infection stimulated RANKL production in various bone marrow cells, including fibroblast-like cells. Treatment with a mAb against mouse RANKL significantly inhibited osteoclast formation and bone resorption. These data suggest that increased expression of RANKL in heterogeneous bone marrow cells provoked bone destruction during GAS infection.
Insights
Group A Streptococcus (GAS) infection in CD46 transgenic mice caused severe bone destruction. This bone loss was driven by increased receptor activator of nuclear factor-κB ligand (RANKL) produced by bone marrow cells, not T-cells.
Area of Science:
- Immunology
- Microbiology
- Orthopedics
Background:
- Human CD46 acts as a receptor for the M protein of Group A Streptococcus (GAS).
- A specific GAS emm1 strain, GAS472, was isolated from a patient with streptococcal toxic shock-like syndrome.
Purpose of the Study:
- To investigate the mechanism of bone destruction caused by GAS infection in a human CD46-expressing transgenic mouse model.
- To determine the role of receptor activator of nuclear factor-κB ligand (RANKL) in GAS-induced bone loss.
Main Methods:
- Subcutaneous infection of CD46 transgenic mice with GAS472.
- Micro-computed tomography (Micro-CT) for bone analysis.
- Immunohistochemistry to assess RANKL and osteoprotegerin expression.
- Treatment with monoclonal antibodies against T-lymphocytes and RANKL.
Main Results:
- GAS472 infection led to necrotizing fasciitis and severe, progressive bone destruction in the hind paws of CD46 Tg mice.
- GAS infection increased RANKL expression and decreased osteoprotegerin in the hind limb bones.
- Micro-CT revealed local bone erosion and systemic bone loss.
- RANKL production was stimulated in various bone marrow cells, including fibroblast-like cells, and blocking RANKL inhibited osteoclast formation and bone resorption.
Conclusions:
- GAS infection can induce significant bone destruction mediated by osteoclast activation.
- Increased RANKL expression in heterogeneous bone marrow cells is a key factor in GAS-induced bone loss.
- Targeting RANKL may be a therapeutic strategy for managing bone destruction during GAS infections.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
MAPK Signaling Cascades
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Stringent Response in E. coli


